Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M400Revenue $M33.9Net Margin (%)-131.2Z-Score-4.6
Enterprise Value $M344EPS $-0.7Operating Margin %-131.5F-Score2
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-131.2Higher ROA y-yN
Price/Book39310-y EBITDA Growth Rate %0Quick Ratio1.6Cash flow > EarningsN
Price/Sales9.25-y EBITDA Growth Rate %0Current Ratio1.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-48.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-244.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M33.9ROI % (ttm)-150.9Gross Margin Increase y-yN

Gurus Latest Trades with VNDA

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VNDAJohn Paulson 2014-06-30 Add0.12%$9.7 - $16.96
($13.27)
$ 12.25-8%Add 129.8%3,200,000
VNDAJohn Paulson 2014-03-31 Buy 0.11%$10.5 - $18.71
($14.13)
$ 12.25-13%New holding, 1392500 sh.1,392,500
VNDAJean-Marie Eveillard 2013-09-30 Sold Out -0.02%$8.05 - $13.031
($10.72)
$ 12.2514%Sold Out0
VNDAJean-Marie Eveillard 2013-06-30 Reduce-0.01%$3.93 - $13
($6.73)
$ 12.2582%Reduce -48.99%975,000
VNDAJean-Marie Eveillard 2012-12-31 Add0.01%$3.03 - $4.16
($3.54)
$ 12.25246%Add 43.16%1,911,452
VNDAJean-Marie Eveillard 2010-03-31 Add0.04%$10.01 - $12.38
($10.94)
$ 12.2512%Add 111.12%752,375
VNDAJean-Marie Eveillard 2009-12-31 Buy 0.04%$9.59 - $11.84
($10.79)
$ 12.2514%New holding, 356375 sh.356,375
VNDAJean-Marie Eveillard 2008-12-31 Add$0.53 - $0.87
($0.7)
$ 12.251650%Add 39.68%123,200
VNDAJean-Marie Eveillard 2008-03-31 Add$2.9 - $5.76
($4.5)
$ 12.25172%Add 162.5%105,000
VNDAJean-Marie Eveillard 2007-12-31 Add$6.79 - $17.41
($10.4)
$ 12.2518%Add 60%40,000
VNDAJean-Marie Eveillard 2007-09-30 Reduce$13.91 - $21.2
($16.6)
$ 12.25-26%Reduce -50%25,000
VNDAJean-Marie Eveillard 2007-06-30 Buy 0.01%$19.42 - $22.44
($20.9)
$ 12.25-41%New holding, 50000 sh.50,000
VNDAGeorge Soros 2006-12-31 Sold Out -0.24%$9.7 - $25.53
($16.3)
$ 12.25-25%Sold Out0
VNDAGeorge Soros 2006-06-30 Buy 0.33%$7.99 - $11
($9.5)
$ 12.2529%New holding, 268495 sh.268,495
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VNDA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VNDA John Paulson 2014-09-303,250,0009.590.14+1.56%
Premium Most recent portfolio changes are included for Premium Members only!


VNDA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Watkins ThomasDirector 2014-03-14Sell35,000$17.66-33.18view
Repella RobertSVP & Chief Commercial Officer 2013-11-21Sell107,500$12.03-1.91view
Kelly James PatrickSVP, CFO, Sec & Treasurer 2013-11-19Sell3,348$12.07-2.24view
Polymeropoulos Mihael HristosPresident and CEO 2013-11-19Sell8,928$12.07-2.24view
Polymeropoulos Mihael HristosPresident and CEO 2012-02-16Sell11,350$4.69151.6view
Feeney John JosephSVP & Chief Medical Officer 2012-02-16Sell4,760$4.65153.76view
Kelly James PatrickSVP, CFO, Sec & Treasurer 2012-02-16Sell4,920$4.67152.68view
Feeney John JosephSVP & Chief Medical Officer 2012-02-16Sell4,760$4.65153.76view
Kelly James PatrickSVP, CFO, Sec & Treasurer 2011-08-29Buy5,000$5.9996.99view
Polymeropoulos Mihael HristosPresident and CEO 2011-08-23Buy10,000$5.35120.56view

Press Releases about VNDA :

    Quarterly/Annual Reports about VNDA:

      News about VNDA:

      Articles On GuruFocus.com
      John Paulson's Stocks Trading for Less Than He Paid for Them Jun 02 2014 
      Best Performing Gurus of Past Six Months are John Paulson, First Eagle and Michael Price Jun 11 2013 
      comment on VNDA Nov 12 2012 
      Vanda: This Company Has Great Assets But No Profits Jan 21 2012 
      Vanda Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 10 2011 
      $VNDA New study started: Oct 15 2010 
      Hourly trend UP Aug 11 2010 
      Vanda Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2010 
      upgraded to BUY Jul 07 2010 
      Vanda Pharmaceuticals Inc. Reports Operating Results (10-Q) May 10 2010 

      More From Other Websites
      Nasdaq stocks posting largest percentage increases Dec 22 2014
      VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers Dec 05 2014
      Vanda Pharmaceuticals to Present at the 26th Annual Piper Jaffray Healthcare Conference Dec 01 2014
      Vanda Pharmaceuticals to Present at the 26th Annual Piper Jaffray Healthcare Conference Dec 01 2014
      Idera Pharmaceuticals Names Vincent J. Milano Chief Executive Officer Dec 01 2014
      Idera Pharmaceuticals Names Vincent J. Milano Chief Executive Officer Dec 01 2014
      Vanda Pharmaceuticals to Present at the Stifel Nicolaus 2014 Healthcare Conference Nov 18 2014
      VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events Nov 03 2014
      VANDA PHARMACEUTICALS INC. Financials Oct 31 2014
      10-Q for Vanda Pharmaceuticals, Inc. Oct 29 2014
      VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Oct 29 2014
      Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock Oct 29 2014
      Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock Oct 29 2014
      Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock Oct 28 2014
      VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 28 2014
      Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock Oct 28 2014
      Twitter Takes A Tumble As Ability To Innovate Comes Into Question Oct 28 2014
      S&P 500 trades in a narrow range, up against key technical levels Oct 27 2014
      Vanda Pharmaceuticals Inc Earnings Call scheduled for 10:00 am ET today Oct 27 2014
      Vanda Pharmaceuticals Reports Third Quarter 2014 Financial Results Oct 27 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK